Assessment Of The Quality Of Services At The Primary Health Care Centers

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01AX03	TEGOZOL	G	Temozolomide - 250mg	250mg	Capsule	13,397,927 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 250mg	250mg	Capsule, hard	13,397,927 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 250mg	250mg	Capsule, hard	12,058,004 L.L
L01AX03	TEMODAL	B	Temozolomide - 100mg	100mg	Capsule	7,731,224 L.L
L01AX03	TEGOZOL	G	Temozolomide - 100mg	100mg	Capsule	5,005,813 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 100mg	100mg	Capsule, hard	5,590,385 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 100mg	100mg	Capsule, hard	4,511,279 L.L
L01AX03	TEMODAL	B	Temozolomide - 20mg	20mg	Capsule	1,612,611 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 20mg	20mg	Capsule, hard	1,153,017 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 20mg	20mg	Capsule, hard	920,532 L.L
L01AX03	TEGOZOL	G	Temozolomide - 20mg	100mg	Capsule	967,567 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 5mg	5mg	Capsule, hard	1,153,017 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 5mg	5mg	Capsule, hard	1,153,017 L.L
L01AC01	TEPADINA	G	Thiotepa - 100mg	100mg	Injectable powder for concentrate for solution	98,197,306 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE	G	Bendamustine HCl - 25mg/10ml	25mg/10ml	Injectable powder for concentrate for solution	19,610,153 L.L
L01AA09	BENDAMUSTINE MEDAC	G	Bendamustine HCl - 2.5mg/ml (25mg)	2.5mg/ml	Injectable powder for concentrate for solution	24,934,922 L.L
L01AA09	RIBOMUSTIN	B	Bendamustine HCl - 100mg	100mg	Injectable powder for concentrate for solution	31,939,807 L.L
L01AA09	RIBOMUSTIN	B	Bendamustine HCl - 100mg	100mg	Injectable powder for concentrate for solution	31,939,807 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE	G	Bendamustine HCl - 100mg/50ml	100mg/50ml	Injectable powder for concentrate for solution	78,439,178 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE GP PHARM	G	Bendamustine HCl - 100mg/50ml	100mg/50ml	Injectable powder for concentrate for solution	78,439,178 L.L
L01AA09	BENDAMUSTINE MEDAC	G	Bendamustine HCl - 2.5mg/ml (100mg)	2.5mg/ml	Injectable powder for concentrate for solution	16,887,989 L.L
L01AA09	BENDAVIVAL	G	Bendamustine HCl - 100mg	100mg	Injectable concentrated powder for solution	26,072,618 L.L
L01AA09	BENDAVIVAL	G	Bendamustine HCl - 100mg	100mg	Injectable concentrated powder for solution	L.L
L01AA06	HOLOXAN	B	Ifosfamide - 1g	1g	Injectable powder for solution	3,586,850 L.L
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	764,646 L.L
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	L.L
J07CA11	DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE	B	Diphteria Toxoid1 - ≤25Lf (≥30IU)/0.5ml, Tetanus toxoid1 - ≥2.5Lf (≥40IU)/0.5ml, Bordetella pertussis (Whole cell) - ≤16OU (≥4.0IU)/0.5ml, HBs Antigen (r DNA)1 - ≥10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - ≤1.25mg , 2 conjugated to tetanos toxoid carrier protein -		Injectable suspension	1,515,854 L.L
J07CA09	INFANRIX HEXA	B	Diphteria toxoid purified (Prefilled syringe) - ≥30IU/0.5ml, Tetanus toxoid purified (prefilled syringe) - ≥40IU/0.5ml, Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg/0.5ml, Poliomyelitis virus type 1 antigen (prefilled syringe) - 40D.U./0.5ml, Poliomyelitis virus type 2 antigen(prefilled syringe) - 8D.U./0.5ml, Poliomyelitis virus type 3 antigen (prefilled syringe) - 32D.U./0.5ml, HBs Antigen (prefilled syringe) - 10mcg/0.5ml, H. Influenza type b polysaccharide (Vial) - 10mcg/0.5ml		Injectable suspension	4,230,416 L.L
J07CA09	HEXAXIM	BioTech	Diphteria Toxoid - ≥20IU/0.5ml, Tetanus toxoid - ≥40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg		Injectable suspension	4,462,901 L.L
J07CA06	INFANRIX IPV + HIB	B	Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ≥40IU, Diphtheria toxoid (Prefilled syringe) - ≥30IU, H. Influenza type b polysaccharide(Vial) - 10mcg		Injectable dry powder+suspension	3,014,239 L.L

تقييم جودة الخدمات في مراكز الرعاية الصحية الاولية